-
161
-
162
-
163
-
164
-
165
-
166
Endoscopic Retrograde Cholangiopancreatography–Induced Splenic Injury in a Patient With Sleeve Gastrectomy
Published 2018-06-01Get full text
Article -
167
-
168
Performing Protest in Cross-Cultural Spaces: Paul Robeson and Othello
Published 2017-06-01Get full text
Article -
169
-
170
Questioning the Problematic Nature of School Culture in Elementary Teacher Education
Published 2019-05-01Get full text
Article -
171
Analysis of tweets mentioning works from an institutional repository
Published 2020-12-01Get full text
Article -
172
Tinnitus Education for Audiologists Is a Ship at Sea: Is It Coming or Going?
Published 2023-05-01Get full text
Article -
173
-
174
Takotsubo cardiomyopathy after microwave ablation of hepatocellular carcinoma
Published 2023-02-01Get full text
Article -
175
Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
Published 2020-06-01Get full text
Article -
176
-
177
Fronto-Temporal Dementia, Diabetes Mellitus and Excessive Eating
Published 2018-05-01Get full text
Article -
178
Kimyrsa and Orbactiv – A Tale of Two Formulations
Published 2023-03-01“…Brittany T Jackson,1 David B Cluck,2 Andrés F Henao-Martínez,3 Daniel B Chastain4 1Department of Pharmacy, Mount Sinai Morningside, New York, NY, 10025, USA; 2Department of Pharmacy Practice, Bill Gatton College of Pharmacy East Tennessee State University, Johnson City, TN, 37614, USA; 3Division of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, CO, 80045, USA; 4Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA, 31701, USACorrespondence: Brittany T Jackson, Department of Pharmacy, Mount Sinai Morningside, New York, NY, 10025, USA, Email brittany.jackson@mountsinai.orgAbstract: Kimyrsa is a new formulation (NF) of the original formulation of oritavancin ([OF] Orbactiv). …”
Get full text
Article -
179
-
180